Neurological disorders in liver transplant candidates: Pathophysiology and clinical assessment (Q39174111)

9 September 2017

title

Neurological disorders in liver transplant candidates: Pathophysiology and clinical assessment (English)

1 reference

9 September 2017

1 reference

Paolo Feltracco

1

1 reference

9 September 2017

Annachiara Cagnin

2

1 reference

9 September 2017

Cristiana Carollo

3

1 reference

9 September 2017

Stefania Barbieri

4

1 reference

9 September 2017

Carlo Ori

5

1 reference

9 September 2017

publication date

27 February 2017

1 reference

9 September 2017

published in

Transplantation Reviews

1 reference

9 September 2017

volume

31

1 reference

9 September 2017

issue

3

1 reference

9 September 2017

page(s)

193-206

1 reference

Neurologic manifestations of gastrointestinal and liver diseases

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Neurological complications of liver cirrhosis and orthotopic liver transplant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

The neurology of liver failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Perioperative neurological complications after liver transplantation are best predicted by pre-transplant hepatic encephalopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

The clinical spectrum of neurologic disorders after intestinal and multivisceral transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Central nervous system syndromes in solid organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Acute confusional state following liver transplantation for alcoholic liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Hepatic myelopathy as a presenting neurological complication in patients with cirrhosis and spontaneous splenorenal shunt.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Alcohol-induced changes in the brain as assessed by MRI and CT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Parkinsonism in cirrhosis: pathogenesis and current therapeutic options

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Neurologic Manifestations of Chronic Liver Disease and Liver Cirrhosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

New assessment of hepatic encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Nomenclature and definition of hepatic encephalopathy - An update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Pathogenesis and diagnosis of hepatic encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

The neurological manifestations of acute liver failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Neurologic manifestations of acute liver failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Pathophysiology of cerebral oedema in acute liver failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Early indicators of prognosis in fulminant hepatic failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Liver transplantation in acute liver failure: A challenging scenario

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Liver and intestine transplantation in the United States, 1997-2006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Role of phosphate-activated glutaminase in the pathogenesis of hepatic encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Mechanisms of cognitive alterations in hyperammonemia and hepatic encephalopathy: therapeutical implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Characterisation of temporal microglia and astrocyte immune responses in bile duct-ligated rat models of cirrhosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Alterations in cerebral white matter and neuropsychology in patients with cirrhosis and falls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Cerebral magnetic resonance imaging reveals marked abnormalities of brain tissue density in patients with cirrhosis without overt hepatic encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Mini-asterixis in hepatic encephalopathy induced by pathologic thalamo-motor-cortical coupling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Focal neurological signs in hepatic encephalopathy in cirrhotic patients: an underestimated entity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Hepatic retinopathia. Changes in retinal function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Falls and cognitive dysfunction impair health-related quality of life in patients with cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Encephalopathy or hepatic encephalopathy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Objective measurement of hepatic encephalopathy by means of automated EEG analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Covert hepatic encephalopathy: agreement and predictive validity of different indices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Neurophysiological assessment of early hepatic encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

A low-cost, user-friendly electroencephalographic recording system for the assessment of hepatic encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

MR imaging findings in hepatic encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Brain magnetic resonance in hepatic encephalopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

7 January 2021

Hepatic Encephalopathy

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Pathophysiology, diagnosis, and management of hepatic encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Review article: the modern management of hepatic encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Is minimal hepatic encephalopathy completely reversible following liver transplantation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Cognitive impairment and electroencephalographic alterations before and after liver transplantation: what is reversible?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Persistence of cognitive impairment after resolution of overt hepatic encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Wilson's disease: etiology, diagnosis, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Wilson's disease: an update.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Neurologic Wilson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Neurological manifestations in Wilson's disease: Report of 119 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Wilson's disease: a clinico-neuropathological autopsy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Teaching NeuroImages: face of the giant panda and her cub: MRI correlates of Wilson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Wilson's disease: a great masquerader

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Diagnosis and treatment of Wilson disease: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

EASL Clinical Practice Guidelines: Wilson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Diagnosis and management of Wilson's disease: results of a single center experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Effects of long-term treatment in Wilson's disease with D-penicillamine and zinc sulphate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Deterioration of Wilson's disease following the start of penicillamine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Liver transplantation for Wilson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Liver transplantation in neurological Wilson's Disease: is there indication? A case report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Eighteen living related liver transplants for Wilson's disease: a single-center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Liver transplantation for Wilson's disease: The burden of neurological and psychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Liver transplantation for Wilson’s disease: long-term results and quality-of-life assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Recovery of neurological deficits in a case of Wilson's disease after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Outcomes of living-related liver transplantation for Wilson's disease: a single-center experience in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Long term results of liver transplantation for Wilson's disease: experience in France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Non-Wilsonian hepatolenticular degeneration: Clinical and MRI observations in four families from south India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Acquired hepatocerebral degeneration and hepatic encephalopathy: correlations and variety of clinical presentations in overt and subclinical liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

False neurotransmitters and hepatic failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Factor structure of the Unified Parkinson's Disease Rating Scale: Motor Examination section

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Reversal of parkinsonism following liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Chronic acquired hepatocerebral degeneration: effects of liver transplantation on neurological manifestations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Magnetic resonance imaging and proton spectroscopic alterations correlate with parkinsonian signs in patients with cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging: probable manganese neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Chronic acquired hepatocerebral degeneration, pallidal T1 MRI hyperintensity and manganese in a series of cirrhotic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Effect of trientine on manganese intoxication in a patient with acquired hepatocerebral degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Clinical and neuroradiological improvement in chronic acquired hepatocerebral degeneration after branched-chain amino acid therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Liver transplantation in a patient with rapid onset parkinsonism-dementia complex induced by manganism secondary to liver failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Are acquired hepatocerebral degeneration and hepatic myelopathy reversible?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Improvement in chronic hepatocerebral degeneration following liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Acquired hepatocerebral degeneration in a patient with HCV cirrhosis: complete resolution with subsequent recurrence after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Hepatic myelopathy: a rare complication following extrahepatic portal vein occlusion and lienorenal shunt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Portosystemic myelopathy: spastic paraparesis after portosystemic shunting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Hepatic myelopathy: a rare complication of portacaval shunt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Use of model for end-stage liver disease exception points for early liver transplantation and successful reversal of hepatic myelopathy with a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Corticospinal involvement in patients with a portosystemic shunt due to liver cirrhosis: a MEP study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Hepatic myelopathy. Case report with review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

The role of liver transplantation in the treatment of hepatic myelopathy: case report with review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Management of surgical splenorenal shunt-related hepatic myelopathy with endovascular interventional techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Spinal cord involvement in patients with cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Mechanisms of hyponatraemia in alcohol patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Risk factors for central pontine and extrapontine myelinolysis after liver transplantation: a single-center study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia. Implications for the pathogenesis of central pontine myelinolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Central pontine and extrapontine myelinolysis: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Osmotic demyelination syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Osmotic demyelination disorders: central pontine and extrapontine myelinolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Treatment of central pontine myelinolysis with plasmapheresis and immunoglobulins in liver transplant patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Reinduction of hyponatremia to treat central pontine myelinolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Osmotic demyelination syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Plasmapheresis improves the outcome of central pontine myelinolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Long-term outcome of patients hospitalized in intensive care units with central or extrapontine myelinolysis*.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Autonomic and peripheral (sensorimotor) neuropathy in chronic liver disease: a clinical and electrophysiologic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Peripheral neuropathy in liver cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Peripheral and cardiovascular autonomic impairment in chronic liver disease: prevalence and relation to hepatic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Autonomic neuropathy in liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Liver: risk of falls in cirrhosis predicted by psychometric testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Rapid improvement of autonomic and peripheral neuropathy after liver transplantation: a single case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Encephalopathy and neuropathy in end-stage liver disease before and after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

Resolution of alcoholic neuropathy following liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRRE.2017.02.006

10.1016/J.TRRE.2017.02.006

7 January 2021

Identifiers

DOI

1 reference

9 September 2017

1 reference